Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy

To clarify the optimal cumulative cisplatin dose (CCD) in locoregionally‐advanced nasopharyngel carcinoma (NPC) patients receiving induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT). Using the NPC‐specific database from the established big‐data intelligence platform at Sun Yat‐Sen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Jia‐Wei, Qi, Zhen‐Yu, Zhou, Guan‐Qun, He, Xiao‐Jun, Chen, Yu‐Pei, Mao, Yan‐Ping, Chen, Lei, Tang, Ling‐Long, Li, Wen‐Fei, Lin, Ai‐Hua, Ma, Jun, Sun, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834779/
https://www.ncbi.nlm.nih.gov/pubmed/29266526
http://dx.doi.org/10.1111/cas.13474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834779/
https://www.ncbi.nlm.nih.gov/pubmed/29266526
http://dx.doi.org/10.1111/cas.13474

Ejemplares similares